JOHNSON & JOHNSON
JOHNSON & JOHNSON
NEW BRUNSWICK, NJ
Loading...
Price History
Market Data
| Market Cap | 533.88B |
| P/E Ratio | 20.07 |
| P/B Ratio | 6.55 |
| EPS | 11.04 |
| Dividend Yield | - |
| D/E Ratio | 1.44 |
| Current Ratio | 1.03 |
| Currency | USD |
Key Financial Metrics
94.19B
Revenue
26.80B
Net Income
11.04
EPS (Diluted)
29.29B
Free Cash Flow
Profitability
Gross Margin
67.9%
Operating Margin
-
Net Profit Margin
28.5%
EBITDA
-
Returns & Efficiency
Return on Assets (ROA)
13.5%
Return on Equity (ROE)
32.9%
Dividend Yield
-
EPS
11.04
Financial Health
Total Assets
199.21B
Total Debt
49.93B
Debt to Equity
1.44x
Current Ratio
1.03
Insider Trading
Last 12 months
0
Buys
0
Sells
0
Insiders
Quick Access Filings
10-K
Annual Report
Loading...
10-Q
Quarterly Report
Loading...
8-K
Recent News
Loading...
Company Data Library
Earnings Transcripts
Loading...
Press Releases
Loading...
Filing Sections
Loading...
Company Info
| Industry | Chemicals & Allied Products |
| HQ | NEW BRUNSWICK, NJ |
| Fiscal Year | 2025 |
Peers
LILLY ELI & CO
LLY
894.82B
P/E: --
ELI LILLY & CO
LLY
894.82B
P/E: --
ABBVIE INC.
ABBV
355.49B
P/E: --
BEIGENE, LTD.
BEIGF
306.50B
P/E: 632.4
BEONE MEDICINES LTD.
BEIGF
306.50B
P/E: 632.4
275.14B
P/E: --
MERCK & CO. INC.
MRK
275.14B
P/E: --
275.14B
P/E: --
Quick Links
Financial Statistics
Valuation
Market Cap$533.88B
P/E Ratio (TTM)20.1
Price to Book6.55
EV/Revenue-
EV/EBITDA-
Profitability
Gross Margin67.9%
Operating Margin-
Net Margin28.5%
ROE32.9%
ROA13.5%
Leverage & Liquidity
Debt to Equity1.44
Current Ratio1.03
Total Debt$49.93B
Total Assets$199.21B
Stockholders' Equity$81.54B
Income Statement (FY 2025)
Revenue$94.19B
Gross Profit$63.94B
Operating Income-
Net Income$26.80B
EPS (Diluted)$11.04
Cash Flow (FY 2025)
Free Cash Flow$29.29B
Cash & Equivalents$19.71B
Revenue Growth6.0%
SEC Filings by Category
Insider Trading Activity
Neutral
0 Buys $0
0 Sales $0
0 Exercises $0
Net: $0
| Insider | Title | Date | Type | Shares | Price | Value |
|---|
Company Information
| Business Address | ONE JOHNSON & JOHNSON PLZ NEW BRUNSWICK, NJ 08933 |
| Phone | 732-524-2455 |
| Incorporated | NJ, US |
| EIN | 221024240 |
| Fiscal Year End | 1231 |
| Shares Outstanding | 2.41B |
| Stockholders' Equity | $81.54B |
| Cash & Equivalents | $19.71B |
Recent Filings
View All
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-05-04
Local
8-K
Current Report
Report of material events (acquisitions, earnings, executive changes)
Filed: 2026-04-28
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-04-27
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-04-27
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-04-27
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-04-27
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-04-27
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-04-27
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-04-27
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-04-27
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-04-27
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-04-27
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-04-27
Local
10-Q
Quarterly Report
Quarterly financial report with unaudited statements
Filed: 2026-04-22
Local
8-K
Current Report
Report of material events (acquisitions, earnings, executive changes)
Filed: 2026-04-14
Local
Loading...
Loading management data...
Loading...
Loading board of directors...
Loading...
Loading institutional holders...
Loading...
Loading short interest data...
Financial Charts Annual (10-K)
Interactive financial visualizations
Show:
Revenue & Income Trends
Revenue & Profit
Profit Margins
Balance Sheet Breakdown
Assets Composition
Capital Structure
Cash Flow Analysis
Cash Flow Components
Free Cash Flow
Growth & Performance
Revenue Growth Rate (YoY %)
Key Ratio Trends
Company Profile
General Information
| Company Name | JOHNSON & JOHNSON |
| Ticker | JNJ |
| Exchange | -- |
| Sector | Manufacturing |
| Industry | Chemicals & Allied Products |
| Headquarters | NEW BRUNSWICK, NJ |
| Fiscal Year | 2025 |
Financial Summary
| Market Cap | 533.88B |
| Revenue | 94.19B |
| Net Income | 26.80B |
| P/E Ratio | 20.07 |
| EPS | 11.04 |
| Net Margin | 28.5% |
| ROE | 32.9% |
| Dividend Yield | - |
Insider Transactions
Loading...
My Notes & Files
Personal Notes
Attached Files
Loading...